Investors following HCA Healthcare, Inc. (NYSE:HCA) will note recent transactions by company executive Chad J. Wasserman, SVP and Chief Information Officer, who has sold a significant amount of company stock. On March 18 and 20, Wasserman disposed of a total of 1,220 shares at prices ranging from $321.97 to $330.25, amounting to over $400,000 in total value.
The transactions took place under a Rule 10b5-1 trading plan, which Wasserman had adopted on November 16, 2023. This plan allows corporate insiders to set up a predetermined schedule for buying and selling securities to avoid accusations of insider trading.
Notably, Wasserman also acquired 2,100 shares of HCA Healthcare common stock on March 18 at a price of $101.16 per share, totaling approximately $212,436. These shares were obtained through the exercise of stock appreciation rights that vested in equal annual installments beginning on January 31, 2019. Following these transactions, Wasserman's direct ownership in the company stands at 1,576.3102 shares.
These financial moves by a key HCA Healthcare executive come as investors keep a close eye on insider activity for signs of company strength and executive confidence. The details of these transactions are publicly available through the company's recent SEC filings.
InvestingPro Insights
The recent insider trading activity at HCA Healthcare (NYSE:HCA) by SVP and Chief Information Officer Chad J. Wasserman has caught the attention of investors. To provide a broader context, InvestingPro data shows that HCA Healthcare has a market capitalization of $86.95 billion and a P/E ratio of 17.18, indicating a valuation that investors might consider reasonable in the context of its earnings. The company's revenue for the last twelve months as of Q4 2023 stands at $64.97 billion, with a solid growth rate of 7.86%, reflecting the company's ability to increase its earnings.
One of the InvestingPro Tips highlights that HCA Healthcare has raised its dividend for three consecutive years, which could be a sign of the company's commitment to returning value to shareholders. Moreover, the company has seen a strong return over the last three months, with a 25.69% price total return, suggesting a positive investor sentiment and potential confidence in the company's future performance.
For investors looking to delve deeper into HCA Healthcare's financials and performance metrics, there are additional InvestingPro Tips available at InvestingPro. Use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, and gain access to a total of 12 tips that provide further insights into HCA's stock performance and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.